Oncolytics grants Adlai Nortye Asian rights to Reolysin

Oncolytics Biotech Inc. (TSX:ONC; OTCQX:ONCYF) granted Adlai Nortye (NEEQ:870946) exclusive rights to develop and commercialize Reolysin

Read the full 163 word article

User Sign In